Literature DB >> 24982265

A cross-sectional study showing differences in the clinical diagnosis of pelvic inflammatory disease according to the experience of clinicians: implications for training and audit.

Georgina C Morris1, Catherine M W Stewart2, Sarah A Schoeman2, Janet D Wilson2.   

Abstract

OBJECTIVES: Pelvic inflammatory disease (PID) generates diagnostic difficulty even for experienced doctors. Junior doctors and nurses also assess women with symptoms suggestive of PID. We aimed to determine if and how PID diagnoses vary between clinicians with different experience levels.
METHODS: Cross-sectional study conducted in U.K. sexual health clinic, nested within a Chlamydia trachomatis (CT), and Neisseria gonorrhoea diagnostic test accuracy study. Proportions and characteristics of women diagnosed clinically with PID by clinicians with varying experience were compared. Outcomes included demographics, presenting symptoms and signs and CT, and CT and/or gonococcal (GC) (CT/GC) positivity.
RESULTS: In 3804 women assessed by 36 clinicians, rates of PID, CT and GC were 4.4%, 10.5%, and 2.5%, with no differences between experienced and inexperienced clinicians (p=0.84, p=0.13 and p=0.07, respectively). 63.7% of PID diagnosed by experienced clinicians met Centers for Disease Control and Prevention (CDC) key clinical criteria versus 41.2% by inexperienced; experienced versus inexperienced OR 2.51; 95% CI 1.16 to 5.40). Proportions of CT (CT/GC)-positive PID increased with experience (5.9% (11.8%) to 31.9% (34.1%)); experienced versus inexperienced (OR 3.90; 95% CI 1.12 to 13.5). Percentages of women with CT (CT/GC) who were diagnosed with PID also rose with experience (2.2% (3.9%) to 14.2% (13.7%)), but CT prevalence in PID cases diagnosed by inexperienced clinicians (8.8%) was no greater than in all women they assessed (9.0%), suggesting poorer discriminative skills.
CONCLUSIONS: Clinical diagnostic acumen for PID improves with experience. Inexperienced clinicians should focus on the presence of lower abdominal pain with pelvic tenderness and consider additional supportive symptoms, to improve specificity of their diagnoses. TRIAL REGISTRATION NUMBER: ISRCTN 42867448. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  DIAGNOSIS; EDUCATION; PELVIC INFLAMMATORY DISEASE

Mesh:

Year:  2014        PMID: 24982265     DOI: 10.1136/sextrans-2014-051646

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  3 in total

1.  Antibiotic therapy for pelvic inflammatory disease.

Authors:  Ricardo F Savaris; Daniele G Fuhrich; Jackson Maissiat; Rui V Duarte; Jonathan Ross
Journal:  Cochrane Database Syst Rev       Date:  2020-08-20

2.  Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study.

Authors:  Helen Bittleston; Jane S Hocking; Jane L Goller; Jacqueline Coombe; Deborah Bateson; Sally Sweeney; Kirsteen Fleming; Wilhelmina M Huston
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

Review 3.  Current perspectives in the USA on the diagnosis and treatment of pelvic inflammatory disease in adolescents.

Authors:  William L Risser; Jan M Risser; Amanda L Risser
Journal:  Adolesc Health Med Ther       Date:  2017-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.